CDH1 and prostate carcinoma: The relationship between E-Cadherin expression and clinico-pathological parameters or prognosis could be analyzed in three cancer types (breast, colorectal, and prostate cancer) derived from normally E-Cadherin positive cells and in two cancer types (papillary and clear cell RCC) derived from normally E-Cadherin negative cells.